There are multiple ErbB family inhibitors available for clinical use, and additional, more selective FGFR inhibitors, such as NYP-BGJ398, are now starting clinical development [ 39].
After 20 years of development, the Kidney Project is due to start clinical trials in early 2018.
To help understand the basic requirements to start a clinical development program, this chapter summarizes the legal definitions and regulations applying to cell-based medicines in Europe.
The date of IND Application to the FDA was taken as the start of clinical development; where this was not available, we used the date that the first clinical trials were undertaken (taken from the published literature) or the date that the first report of clinical trials (typically phase I) was published instead.
One technique starting clinical trials uses ultrasound.
It is therefore unsurprising that anti-obesity drug discovery programmes have been littered with false starts, failures in clinical development, and withdrawals due to adverse effects that were not fully appreciated at the time of launch.
5 9 In broad terms, drug development begins with discovery and preclinical laboratory research, before moving on to clinical development, starting with first testing in humans (phase I clinical trials) and continuing until regulatory review and approval.
The purpose of this report is to provide a comprehensive review of the safety of drotrecogin alfa (activated) for all adult patients with severe sepsis enrolled in clinical trials (completed and ongoing) since the start of phase 2 clinical development and up to 12 April 2002.
Cabozantinib has a rational clinical development plan starting with the indication in an orphan status disease, ie, medullary thyroid cancer.
In this context, NGR-mTNF showed a significant antitumour activity at very low doses (0.1 ng per mouse, corresponding to 5 ng per kg) (Curnis et al, 2000), equivalent in humans to a dose of 0.2 μg m−2, which was the selected starting dose for phase I clinical development.
